{"id":488748,"date":"2024-01-17T08:30:03","date_gmt":"2024-01-17T13:30:03","guid":{"rendered":"https:\/\/platohealth.ai\/success-in-selectivity-giving-sites-the-power-to-pick-the-right-trials-acrp\/"},"modified":"2024-01-17T16:42:40","modified_gmt":"2024-01-17T21:42:40","slug":"success-in-selectivity-giving-sites-the-power-to-pick-the-right-trials-acrp","status":"publish","type":"post","link":"https:\/\/platohealth.ai\/success-in-selectivity-giving-sites-the-power-to-pick-the-right-trials-acrp\/","title":{"rendered":"Success in Selectivity: Giving Sites the Power to Pick the Right Trials – ACRP","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"
The current site selection process has left many research sites unable to realize their full potential, limiting their ability to deliver optimal results. However, amidst these enduring challenges, a shift in power is under way.<\/p>\n
Today, large academic research centers receive the vast majority of trial opportunities, leaving countless other sites constrained by studies that don\u2019t align with their strengths. It\u2019s not uncommon for experienced and motivated sites to accept the majority of opportunities that come their way, even when it\u2019s not the best match for their team and patients. This results in highly qualified sites underperforming across trials \u2013 not because they lack the ability to deliver results, but because they lack the power to be strategic and selective in choosing trials.<\/p>\n
I am optimistic that the tides are turning in the clinical trial ecosystem. New tech solutions, coupled with heightened U.S. Food and Drug Administration (FDA) pressure on sponsors, are tipping the balance in favor of research sites, granting them the power to be more selective. It sounds counterintuitive to refuse opportunities when, in the current climate, many sites don\u2019t have a guarantee for the next time they\u2019ll be offered a trial. However, as we see the FDA diversity plans go into effect and a focus on community relationships takes the spotlight, the sites that see the most success will be the ones that are picky about which trials they take on.<\/p>\n
Refusing wrong-fit trials doesn\u2019t mean limiting opportunities, it means taking the reins and ultimately seeing long-term benefits like saving time, establishing a reputation as a high performer, building a robust track record for securing the right trials, and avoiding unnecessary challenges.<\/p>\n
In my current role, working closely with both sites and sponsors on our marketplace, I\u2019ve had the privilege of listening to the pain points and priorities of both sides. Based on these insights, here are three steps I believe will grant sites the power of being picky:<\/p>\n
When faced with a new trial opportunity, getting the necessary details to make an informed decision is not only time-consuming, it\u2019s incredibly rare. Sponsors often fall short in giving sites enough information upfront to enable confident decision-making. While sites may not have the ability to change this dynamic, they can take charge by proactively establishing criteria with their teams for identifying the right-fit trials.<\/p>\n How? By answering questions like:<\/p>\n Sites can confidently navigate trial opportunities to ensure they align with their strengths and needs.<\/p>\n The answers to these questions will be the compass to navigating the decision-making process more efficiently. Some sponsor criteria are absolute, so when the answers to these questions indicate a trial might not be the right fit, the decision to move on to opportunities that promise a more valuable use of the site\u2019s time is made easier.<\/p>\n The traditional data sources sponsors have access to when selecting sites are typically limited to trial experience, historical performance, and staff CV details. Not only does this mean sponsors are making decisions without the full story, but also sites with rich community connections and experienced teams aren\u2019t able to showcase the full scope of their strengths. New technology solutions, including Inato\u2019s marketplace, are changing how sites present their qualifications to sponsors and putting the spotlight on important attributes like:<\/p>\n Sites that can communicate this information to sponsors will boost their opportunities in being selected, giving themselves an extra cushion of reassurance when turning down trials that don\u2019t align and crucially transforming how sponsors view community-based sites.<\/p>\n In light of the FDA guidance and pending regulations, sites\u2019 community engagement is becoming increasingly vital in clinical research. Sponsors know that sites with longstanding patient relationships and a trusted, reliable presence in the area are the ones that shine in recruitment and retention, especially when it comes to underrepresented populations. At Inato, we\u2019ve seen firsthand how sites with dedicated community initiatives stand out to sponsors and deliver outstanding trial results.<\/p>\n Some programs that have brought success to community-based sites on our marketplace include:<\/p>\n (For more tips, our team at Inato created a free guidebook<\/a> with strategies research sites can use to maximize their community engagement).<\/p>\n These initiatives reassure sponsors of the commitment research sites have to building trusted relationships with local patients and bringing them into research. Sponsors want to hear about these programs, so the more sites are able to share additional information about their community relationships, the more they can stand out to the sponsor and feel confident when applying to trials.<\/p>\n Making the decision to be picky won\u2019t be easy, and the steps to building the confidence and protection to ensure it\u2019s a sustainable decision require a team effort. Nonetheless, in the long run, sites that take these steps will see themselves and their teams succeed across trials that truly fit their needs, bringing the right opportunities to their patients and contributing to the development of innovative treatments<\/span><\/span>.<\/span><\/span><\/p>\n Learn more and sign up at inato.com<\/a>.<\/p>\n This is a sponsored message. The current site selection process has left many research sites unable to realize their full potential, limiting their ability to deliver optimal results. However, amidst these enduring challenges, a shift in power is under way. Today, large academic research centers receive the vast majority of trial opportunities, leaving countless other […]<\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"author":2,"featured_media":488751,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49],"tags":[],"acf":[],"gt_translate_keys":[{"key":"link","format":"url"}],"_links":{"self":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/488748"}],"collection":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/comments?post=488748"}],"version-history":[{"count":1,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/488748\/revisions"}],"predecessor-version":[{"id":488750,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/488748\/revisions\/488750"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/media\/488751"}],"wp:attachment":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/media?parent=488748"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/categories?post=488748"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/tags?post=488748"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Step 1: Be proactive in defining your ideal trials<\/strong><\/p>\n\n
Step 2: Tell the full story<\/strong><\/p>\n\n
Step 3: Stand out with diversity and community engagement<\/strong><\/p>\n\n
Inato\u2019s marketplace is striving to be a part of this progress. It is completely free for sites and gives them the chance to take these steps and be more strategic with which trials they bring to their patients. After signing up, sites gain access to top sponsor trials and have the opportunity to apply to the ones that are right for them, showcasing holistic attributes to stand out to sponsors and boosting their chances of getting selected.<\/p>\n
\n